MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Lexicon Pharmaceuticals Long Term Debt Current 2011-2026 | LXRX
Annual Long Term Debt Current Lexicon Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.18 M | 1.29 M | 1.29 M | 1.09 M | 553 K | 11 M | 1.12 M | 14.1 M | 16.3 M | 2.02 M | 20.2 M | 1.71 M | 1.57 M | 1.44 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.2 M | 553 K | 5.34 M |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
433 K | $ 0.84 | - | $ 4.58 M |  China |
 |
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | USA |
 |
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M |  Canada |
 |
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | China |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | USA |
 |
Amarin Corporation plc
AMRN
|
1.87 M | $ 15.02 | - | $ 6.12 B |  Irlanda |
 |
Adagene
ADAG
|
1.18 M | $ 2.98 | - | $ 168 M | China |
 |
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | USA |
 |
BioNTech SE
BNTX
|
39.5 M | $ 108.93 | - | $ 27.2 B | Germany |
 |
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.48 | -0.86 % | $ 8.37 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | USA |
 |
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | USA |
 |
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 4.34 | - | $ 9.44 B |  Israel |
 |
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | USA |
 |
Brickell Biotech
BBI
|
49 K | - | -5.38 % | $ 6.06 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
14.2 M | $ 224.05 | -0.06 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
BeiGene, Ltd.
BGNE
|
17.6 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Aridis Pharmaceuticals
ARDS
|
538 K | - | 17.91 % | $ 11.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | USA |
 |
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | USA |
 |
Baudax Bio
BXRX
|
5.6 M | - | 0.59 % | $ 63 K | USA |
 |
Cabaletta Bio
CABA
|
3.56 M | $ 2.6 | - | $ 3.04 M | USA |
 |
Calithera Biosciences
CALA
|
1.37 M | - | -10.95 % | $ 876 K | USA |
 |
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.43 | - | $ 365 M |  Britain |
 |
Catalyst Pharmaceuticals
CPRX
|
402 K | $ 24.27 | - | $ 2.87 B | USA |
 |
Amneal Pharmaceuticals
AMRX
|
224 M | $ 14.76 | - | $ 4.56 B | USA |
 |
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | USA |
 |
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | USA |
|
Champions Oncology
CSBR
|
1.47 M | $ 6.12 | -6.56 % | $ 83.6 M | USA |